Exchange: NYSE·Updated 10:18 AM EDT
BSX logo

BSX Boston Scientific Corp.

$42.89
$0.16
(0.37%)
Today
EarningsOct 28
Mkt Cap$61.93B
Vol776,926.00

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
63

Bullish Sentiment

How do you feel about BSX?

mstan
$BSX large volume last 3 days could signal that the bottom is in. Institutional ownership 95%. Monthly and weekly RSI 28&32 in oversold territory. Large Insider buys, buybacks and still strong fundamenetals with LT growth is hard to ignore.
9
Quant73
$BSX Lower prices keep getting rejected. Nice Dragonfly on the Daily. Back above $44 should propel a test of the Call Wall at $45.
8
JCRedeemed
$BSX So let me get this straight, there was a cyber attack that disrupted manufacturing that was fixed almost immediately. Management is saying that the Q3 numbers will still be good, but the market beat this thing in almost half of the 52 week high? I see profitable calls in my future on this one.
1
5
Bargainhunters
$BSX The companies with poorest sentiments and excellent fundamentals are the ones that will turnaround and give 70-100 percent return in 12-/24 months I like BSX and will accumulate more on any weakness
8
BluntForceOptions
$BSX Good morning, all. A quick word of perspective for long-term holders... Seeing heavy frustration across the feeds lately, which is completely understandable after a 58% haircut from the 52 wk high. But volatile washouts are where conviction is actually tested. In business, you get operational bottlenecks, regulatory friction, and sudden headwinds... it’s simply the price of admission. Taking profits and stepping aside tactically to manage risk--as I recently did--is one thing. Confusing near-term operational friction with permanent franchise impairment is quite another, and that's usually how investors get shaken out at the lows. No question, IMO, that the underlying franchise value here remains substantial. At ~3.2x sales, valuation is sitting near a decade trough (down from peaks of 8.6x). While WATCHMAN and electrophysiology have hit well-documented headwinds, the rest of the portfolio--roughly 75% of total revs--is still growing at around 6%, led by Interventional Cardiology (+15% in Q2). More importantly, operating margins have expanded for three consecutive years (from 16.6% up to 21% TTM). Multiple compression while profitability actually improves isn't a broken business; it’s washed-out sentiment. If your horizon is multi-year and you’ve done the fundamental homework, tune out the daily feed panic. In my experience, great franchises navigate the mud and come out stronger. As always, just my two cents. Wishing everyone solid discipline and great success navigating this cycle.
8
TPTradingCo
$BSX about to double bottom and traverse onwards and upwards into the end of the year. Largest position. Down 15%. Have been wrong the entire year.
7
AJTrading39
$BSX just need to break this downtrend on volume. This thing has held serious support to this point.
7
dontbesoconfident
$BSX Looks like it might have formed the basis for a double (or maybe even a triple) bottom. If true, that's promising from here, IMHO. That being said, it was strange how the mgmt team was so eager to not only warn of the material impact of the stupid cybersecurity incident but also to drop the guidance for Q3 and the entire FY all together.
1
4
OptionTradingWithSteve
$BSX #BSX Bounced on long term support of 42.67, Today we GAPPED UP and is started a Bullish Harami on the Weekly chart. We have resistance at 45.16 but most likely go to 46.67 then next week go higher towards 49.15 then from there form a inverse H&S on that 49 area as the neckline, where we can potentially fire up towards 52-54 after that right shoulder fills out. But we are at the bottom of the inverse H&S and the Bullish harami, so ti will takes some time for 54, so lets watch out for 46-48 then 49 for now #OTWSWatchlist
7
Equity30
$BSX Just remember, they did a $2B share repurchase this year at $50/sh, and the CEO purchased $9M of stock Open Market at $48. Easy short-term price target of 50 especially when we see continued growth of Penumbra while the acquisition is pending.
6
thetraderB
$BSX Still just barely hanging on to support at this demand zone. Today might be the last opportunity for price to hold and show some signs of bullish intent. A close below $42.50 likely takes us to $37
1
3
Togdjclecj
$BSX I always try to really enjoy green when we get it. This morning was just a really nice experience for 7 minutes.
6
Comox
$BSX I’m not even frustrated with the analysts anymore. At this point, my frustration is entirely with management. Seriously, how difficult is it to get things under control and communicate something positive for once? It feels like every update brings another piece of bad news, and the constant negativity is becoming exhausting. At some point, accountability has to start at the top. I genuinely believe it’s time to reconsider the CEO’s leadership. This management team is making an already frustrating situation even worse. Honestly, what a way to ruin my day.
6
dontbesoconfident
$BSX It is definitely not the best day for the stock but the sellers are not going to succeed IMHO to push it further down. All bad news and the worst case scenario are fully priced in, IMHO. I'm keeping in mind that 1) a lower stock price a the close of the Penumbra acquisition will reduce the total outlay of the transaction 2) there is an additional $3B for the stock repurchase program that was authorized by the board 3) $BSX historical P/E is around 24 and it is around 12 today... 4) there is an interesting formation on the chart that could lead to better days in the short to mid-term As always, do your research as this is just my (lame) personal opinion. The bears will be defeated....
1
2
St0ckt0k101
$BSX like I’ve said every day this stock closes above $42 is a WIN‼️ Long recovery road ahead but $48-$52 is likely on a bounce short term, 90-120 days out from now. 2028 we see $75+ again easily. THIS WONT STAY DOWN FOREVER but 2026📉 completely lost year smh💯
5
FOUNDRY123
$BSX prediction - rises 1.02 percent in the AM and finishes the day ar -.42 percent. just a feeling
1
2
Comox
$BSX The confidence you have while pulling half this shit out of thin air is fucking impressive. “$35 after earnings” — source: trust me bro. “Top line won’t grow until 2028” — bro is apparently living in 2029 already. “Morale is at an all-time low” — did you personally interview every employee? You’ve turned every negative possibility into a guaranteed outcome and somehow think that makes you an analyst. At this point just short the fucking company and stop writing your breakup letter to BSX. And before you think I’m defending this shitshow — I fucking hate what BSX and this management team have been doing too. I just don’t confuse being pissed off with having a crystal ball.
5
FiveKegs
$BSX stock is going to drift lower and next stop after earnings is $35. Sales growth has slowed significantly Price will not rebound until the top line starts growing and that’s not until 2028 at the earliest Morale is at all time low. Massive headcount reduction going on so do you think that will lead to sales growth??? Take your cash somewhere else. Don’t fight reality
1
2
Comox
$BSX If BSX has 100 haters, I’m one of them. If BSX has 10 haters, I’m still one of them. If BSX has 1 hater, that’s me. If BSX has 0 haters, then it means I’m gone from this world. Fuck this POS stock.
5
TeamJayDay
Boston Scientific is down 21% over the past 30 days and 60% from its 52 week highs of $109-105. The CEO purchased shares at higher prices, and I still see a lot to like here. Boston Scientific has a strong portfolio of medical devices, leading positions in cardiovascular and minimally invasive procedures, and long term growth opportunities across its healthcare businesses. The stock has pulled back significantly since my last post, where I said I’d rather wait for another pullback. This could be a nice average area. $BSX $DIA $SPY $QQQ $IWM
1
2

Advertisement|Remove ads.